City of Industry, CA --(www.USEquityNews.com)-- 10/31/2007 - Biotechnology industry alert provided by U.S. Equity News. RXi Pharmaceuticals Corporation, a majority owned subsidiary of CytRx Corporation (NASDAQ: CYTR), announced recently that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the registration of its common stock owned by CytRx Corporation. The registration statement filed by RXi covers shares of RXi common stock that will be distributed to CytRx's stockholders and awarded to certain directors, officers and other employees of CytRx. The registration statement also covers the resale of RXi shares to be held by CytRx after the distribution and award transactions.

Emergency Disaster Systems, Inc., a subsidiary of U.S. BioDefense, Inc. (OTCBB: UBDE) assists Certified Emergency Response Teams (CERT) in California by donating supplies. These supplies include emergency blankets, disposable gloves and dust masks. All CERT groups that have not been notified can contact Emergency Disaster Systems by calling (866) MyEDSkit or email cs@myedskit.com to receive their supplies. "We would like to support all fire departments, CERT, and volunteers that are assisting the victims of this tragic event," said David Chin, CEO of U.S. BioDefense.

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) recently announced that Adrian Adams has been elected to the company's Board of Directors effective immediately. "We are very pleased to welcome Adrian to the Amylin Board," said Daniel M. Bradbury, President and CEO of Amylin Pharmaceuticals. "His international experience as a highly innovative, strategic business leader, combined with a track record of building organizations and delivering optimum results will enhance our Board's depth of experience."

Invitrogen Corp. (NASDAQ: IVGN), a biotechnology research firm, said recently it swung to a profit in the third quarter after selling money-losing businesses. Net income rose to $31 million, or 64 cents per share, versus a loss of $129.8 million, or $2.47 per share, in the year-ago period, which included a loss of $145.6 million on discontinued operations. Earnings adjusted to exclude certain items of the company's choosing rose to $1.15 per share from 82 cents per share last year.

About U.S. Equity News

U.S. Equity News provides information, resources and news services for investors of small-cap, micro-cap and emerging companies. U.S. Equity News distributes RSS news feeds and a free subscription-based newsletter available through its website at www.usequitynews.com.

U.S. Equity News is a financial news distribution service by Equity Solutions, Inc. (www.equityirsolutions.com) that provides a platform for public companies to disseminate important news to key Wall Street interest such as shareholders and new investors. Equity Solutions, Inc. can assist by providing an effective increase in the awareness of a public company's news, development and corporate story through its proprietary network and its financial portal. U.S. Equity News and its affiliates charge each client cash for news distribution and may take an equity position in the companies mentioned herein, please visit the disclaimer at www.USEquityNews.com

Contact Information:
U.S. Equity News
Tel: (626) 961-8039
Email: info@usequitynews.com

EMAIL THIS RELEASE
Your Name:
From Email:
To Email:
Message: